Filing Details

Accession Number:
0001493152-24-049433
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-10 14:04:37
Reporting Period:
2024-08-30
Accepted Time:
2024-12-10 14:04:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011060 Nordicus Partners Corp NORD Services-Management Consulting Services (8742) 043186647
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1939150 Aps Partners Gk Dyrehavevej 3 B
Klampenborg G7 DK-2930
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-03 500 $10.00 2,245,956 No 4 P Direct
Common Stock Acquisiton 2024-10-01 5,000 $10.00 2,250,956 No 4 P Direct
Common Stock Acquisiton 2024-11-12 1,076,412 $0.00 3,349,568 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 J Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2024-08-30 3,400 $10.00 600,000 $10.00
Common Stock Warrant Acquisiton 2024-10-03 3,200 $10.00 600,000 $10.00
Common Stock Warrant Acquisiton 2024-10-17 12,000 $10.00 600,000 $10.00
Common Stock Warrant Acquisiton 2024-11-01 3,500 $10.00 600,000 $10.00
Common Stock Warrant Acquisiton 2024-11-06 3,500 $10.00 600,000 $10.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
532,500 2022-04-01 2023-12-31 No 4 O Direct
529,300 2022-04-01 2023-12-31 No 4 O Direct
517,300 2022-04-01 2023-12-31 No 4 O Direct
513,800 2022-04-01 2023-12-31 No 4 O Direct
510,300 2022-04-01 2023-12-31 No 4 O Direct
Footnotes
  1. Shares acquired in connection with the acquisition by Nordicus Partners Corporation through a share exchange with the shareholders of Bio-Convert ApS (893,268 shares) and in connection with the acquisition by Nordicus Partners Corporation of Orocidin A/S (183,144 shares) on November 12, 2024.